Nice to see a little bit of life breathed into the share price today. Would like to see a sustained upward trend as opposed to the quick retreat we've witnessed in recent times.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%